Skip to content

Study of Therapeutic Exercise in Acute Respiratory Failure to Improve Neuromuscular Disability Trial

Study of Therapeutic Exercise in Acute Respiratory Failure to Improve Neuromuscular Disability Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03863470
Acronym
STAND
Enrollment
1917
Registered
2019-03-05
Start date
2019-03-04
Completion date
2020-07-30
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Critical Illness

Keywords

Early ICU mobility

Brief summary

This is a stepped-wedge, cluster randomized, trial evaluating the effect of an early goal-directed mobilization intervention for ICU patients with acute respiratory failure within 12 medical and surgical ICUs across 4 hospitals in the University of Pennsylvania Health System. The investigators will conduct a 54-week trial to measure the effect of the intervention on multiple patient-centered outcomes of patient physical function and cognition, in addition to ICU and hospital length of stay and duration of mechanical ventilation compared to usual care.

Detailed description

The STAND trial aims to measure the effect of an early goal-directed mobilization algorithm versus usual care for ICU patients with acute respiratory failure in the medical and surgical ICUs across University of Pennsylvania Health System (UPHS) with respect to patient-centered outcomes of patient physical function and cognition as well as multiple secondary clinical outcomes. To achieve this goal, the investigators will conduct a 54-week stepped-wedge, cluster randomized, trial to test the intervention during the course of providing usual care among a large and diverse population of patients admitted to 12 ICUs across 4 hospitals within UPHS. The intervention is an early mobilization protocol implemented during a patient's stay in the ICU. It involves three steps: 1) the clinical team will set a standardized mobility goal for each patient during morning rounds and display the goal on the patient's door; 2) a facilitator will be established in the ICU to communicate mobility goals and activities across clinical personnel shifts; 3) patient mobility scores will be displayed to clinical and administrative staff in the ICU via the ICU board. Approximately 1,500 adult patients with continuous mechanical ventilation for ≥48 hours (without interruption) and baseline independent ambulatory status will be enrolled. Participating ICUs will be randomized into 6 clusters of 2 ICUs each. Each ICU contributes a minimum of 12 weeks of data under the usual care control condition prior to implementing the early mobilization intervention. Then, using the stepped-wedge design, all ICUs will implement the intervention in 6-week intervals with the order and timing of implementation determined by random assignment. By the end of the trial, all ICUs will have utilized the intervention for at least 12 weeks. The primary outcome is peak patient activity level as measure by the ICU mobility score (IMS) at ICU discharge. Secondary outcomes include an array of clinical outcomes.

Interventions

BEHAVIORALEarly mobilization intervention

The intervention consists of 3 components: 1) A simplified mobilization goal (using the Surgical Optimal Mobility Score) will be defined during daily morning ward rounds and displayed on the doors of patients' rooms; 2) a facilitator will communicate to the care team regarding mobility goals; 3) clinicians will receive feedback on patient's mobility as mobility scores will be made available electronically on the ICU board - a dashboard for monitoring patient care in the ICU

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years old; AND * Admission to 1 of 12 participating ICUs; AND * Continuous mechanical ventilation for ≥ 48 hours (without interruption); AND * Baseline independent ambulatory status

Exclusion criteria

* Admitting diagnosis of any of the following conditions: * Cardiopulmonary arrest * Raised intracranial pressure * Acute neurological admission diagnosis * Subarachnoid hemorrhage * Ischemic stroke

Design outcomes

Primary

MeasureTime frameDescription
Peak hour patient activity levelWithin 48 hours of ICU dischargePeak hour patient activity level as measured by the ICU mobility score (IMS) at ICU discharge. IMS score ranges from 0 to 10.

Secondary

MeasureTime frameDescription
ICU length of stayFrom ICU admission to ICU discharge, approximately 3 daysICU length of stay (days)
Hospital length of stayFrom hospital admission to hospital discharge, approximately 5 daysHospital length of stay (days)
Duration of mechanical ventilationFrom hospital admission to hospital discharge, approximately 5 daysDuration of time spent on continuous mechanical ventilation (hours)
ICU mortalityFrom ICU admission to ICU discharge, approximately 3 daysICU Mortality
Neurological functionFrom hospital admission to hospital discharge, approximately 5 daysComposite measure of delirium and coma free days
Richmond Agitation-Sedation Scale (RASS)From hospital admission to hospital discharge, approximately 5 daysRASS score at time of first spontaneous breathing trial. RASS score ranges from -5 (unarousable) to +4 (combative); A score of 0 = alert and calm.
Duration of time spent in deep sedationFrom hospital admission to hospital discharge, approximately 5 daysDuration of time spent in deep sedation (hours)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026